ClinicalTrials.Veeva

Menu

Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.

M

Minia University

Status

Unknown

Conditions

Analgesia
Rib Fractures

Treatments

Procedure: Control
Procedure: Serratus anterior plane block
Procedure: Thoracic Paravertebral block

Study type

Interventional

Funder types

Other

Identifiers

NCT04554186
112-11/2018

Details and patient eligibility

About

Compare between serratus anterior plane block and thoracic Paravertebral block in analgesia for patients with multiple rib fractures

Full description

The study will be conducted in a prospective randomised controlled. Patients will be allocated into three groups

Control group:

The patient will receive fentanyl patch 50 microgram

TPVB group:

The patient will receive thoracic vertebral plane lock 0.4ml/kg bupivacaine 0.1 25% will be administered. For continuous infusion catheter will be inserted . Then a rate of 7ml / hour to max 10 ml / hour of bupivacaine 0.0625%

SAPB group,:

Patient will receive serratus anterior plane block 0.4ml / kg bupivacaine 0.125% will be injected to open the space then a catheter will be advanced For continuous infusion of 0.0625 % bupivacaine at 7 ml / hour

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA 1_3 Age 18_60 Unilateral fracture ribs

Exclusion criteria

  • Drug allergy Morbid obese Opioid dependence Patients refuse

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups, including a placebo group

Serratus anterior plane block
Experimental group
Description:
20 patients will receive SAP block with 0.4 ml / kg bupivacaine 0.125% then continuous infusion through a catheter at rate of 7 ml / hour to max 10 ml / hour of bupivacaine 0.0625%
Treatment:
Procedure: Serratus anterior plane block
Thoracic Paravertebral block
Active Comparator group
Description:
20 patients will receive TPVB 0.4ml / kg bupivacaine 0.125% then continuous infusion through a catheter at rate of 7 ml / hour to max 10 ml / hour of bupivacaine 0.0625%
Treatment:
Procedure: Thoracic Paravertebral block
Control group
Placebo Comparator group
Description:
20 patients will receive Fentanyl patch 50 microgram
Treatment:
Procedure: Control

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed G Shehata, Master; Omyma M Shehata, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems